The RAF/MAP kinase cascade is highly mutated in cancer, RAS mutations are found in ∼30% of all human cancers, and the most active activator of this pathway is BRAF, which is reported to be mutated in ∼7% of cancers, including breast cancer [19]. Here, BRAF is linked to breast carcinoma.